We showed that >60% of breast cancer samples exhibited strong or extra-strong staining for both of RBMS1 and PD-L1, whereas most of the normal breast tissues (~80%) displayed weak positive/negative staining for RBMS1 and PD-L1 (Fig. 1G, H). This evidence concerns the gene CD274 and breast carcinoma.